Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab

NCT01197144 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Arthritis, Rheumatoid
Pain
Fatigue

Interventions

DRUG: adalimumab
DRUG: Placebo

Sponsor

Karolinska Institutet

Collaborators

[object Object]
[object Object]
[object Object]